The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...
Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...